Loading stock…

DENTSPLY SIRONA Inc. (XRAY) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

DENTSPLY SIRONA Inc.

XRAYMarket cap $1.70BPrice $8.5

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes dental equipment and consumable supplies used by dentists worldwide, from implants to imaging systems. It's one of the largest dental companies globally, touching nearly every stage of oral care from checkup to surgery.

In Bastion Portfolios?

52W Return-31%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-2%2

Revenue Forecast

Rev CAGR (1y)-3%2

Rev CAGR (3y)+0%1

Rev CAGR (5y)+2%2

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2-5%3

EPS Growth Y+3+10%6

Quality

Margins

EBIT Margin5%3

Net Income Margin-15%1

Free Cash Flow Margin4%4

Debt

Net Debt/EBITDA3.42

Efficiency

ROE-33%1

ROA-10%1

Earnings Stability22

GEAR+VERY WEAK10

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)610

P/E Ratio (Forward 3y)510

P/BV1.39

EV Multiples

EV/EBITDA Fwd69

EV/EBIT Fwd89

Yield

Free Cash Flow Yield8.4%9

Dividend Yield7.5%10

Momentum

Short term

1 month return-25%1

3 month return-30%1

YTD return-25%2

Mid term

Price vs 52wHigh58%2

1 year return-30%2

Long term

3 year return-72%1

5 year return-84%1

Risk Shield

Price Risk

Beta0.76

Volatility47%3

Free Cash Flow

Free Cash Flow Margin4%4

Free Cash Flow Yield8.4%9

Quality

ROCE4%3

Earnings Stability22

Net Debt/EBITDA3.42

02Growth

Is it actually growing, and how fast?

XRAYDENTSPLY SIRONA

Revenue FY25$3.7B

GROWTH RATING↗

VERY WEAK5 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+0%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E-5%3

EPS growth, FY28E+10%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue fell 2%/yr over the last 3 years and is set to grow around 0.4%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 95% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to hold flat over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK2 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-25%1

3-month return-30%1

YTD return-25%2

MID & LONG-TERM▾SCORE

% of 52-week high58%2

1-year return-30%2

3-year return-72%1

5-year return-84%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-72% over three years and -84% over five), behind 90% of the market.

It's down 30% over the past year, now 42% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-25%), over three months (-30%) and so far this year (-25%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on DENTSPLY SIRONA Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

XRAYDENTSPLY SIRONA

Revenue FY25$3.7B

GROWTH RATING↗

VERY WEAK5 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+0%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E-5%3

EPS growth, FY28E+10%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue fell 2%/yr over the last 3 years and is set to grow around 0.4%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 95% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to hold flat over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK2 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-25%1

3-month return-30%1

YTD return-25%2

MID & LONG-TERM▾SCORE

% of 52-week high58%2

1-year return-30%2

3-year return-72%1

5-year return-84%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-72% over three years and -84% over five), behind 90% of the market.

It's down 30% over the past year, now 42% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-25%), over three months (-30%) and so far this year (-25%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on DENTSPLY SIRONA Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community